Indivumed
Hamburg
About Indivumed
Indivumed was founded in Hamburg, Germany in 2002 with one main driver – the individualization of cancer therapy through the generation, characterization, and analysis of biologic samples from human cancer patients. Since then, the company has expanded globally, with a subsidiary in the USA, partnerships with leading cancer clinics in Europe, the US and Asia and more than 50 oncology practices located in Germany, and, finally, more than 100 biopharma industry partners – and a global reputation for product and service quality.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: Less than $1M
- Total funding: $47.7M
- Last round: Debt Financing (Jan 2018)
- Website: indivumed.com
- Phone: +49 (40) 41 33 83 0
Industries & Categories
Biotechnology, Clinical Trials, Oncology, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/indivumed-80116 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.